Who owns ACRS?
Institutional ownership of Aclaris Therapeutics Inc. from Form 13F, Q2 2026
149 institutional managers reported holding Aclaris Therapeutics Inc. (ACRS) in Form 13F filings for Q2 2026, with 121,170,637 shares worth $641M. The largest reported holder was Ra Capital Management, L.p. Managers that filed both quarters added a net 10,622,779 shares (+9.6%). 28 opened new positions and 14 sold out.
- Funds holding
- 149
- Value held
- $641M
- New / sold out
- 28 / 14
- Net shares, same filers
- +9.6%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of ACRS
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| Ra Capital Management, L.p. | $67.3M | 10.5% | 12,723,026 | Added |
| BML Capital Management, LLC | $63.3M | 9.9% | 11,975,000 | Trimmed |
| BlackRock, Inc. | $53.1M | 8.3% | 10,037,008 | Added |
| Deep Track Capital, LP | $49.4M | 7.7% | 9,345,000 | Unchanged |
| Vivo Capital, LLC | $35.4M | 5.5% | 6,694,637 | Added |
| Vanguard Capital Management LLC | $30.8M | 4.8% | 5,817,866 | Added |
| Frazier Life Sciences Management, L.P. | $26.1M | 4.1% | 4,925,374 | Unchanged |
| Rock Springs Capital Management LP | $22.9M | 3.6% | 4,330,532 | Trimmed |
| Adage Capital Partners GP, L.l.c. | $21.5M | 3.4% | 4,071,000 | Added |
| Decheng Capital LLC | $21.4M | 3.3% | 4,041,736 | Unchanged |
| Kalehua Capital Management LLC | $19.4M | 3.0% | 3,664,730 | Added |
| State Street Corp | $17.2M | 2.7% | 3,255,340 | Added |
| Geode Capital Management, LLC | $16.9M | 2.6% | 3,190,058 | Added |
| Braidwell LP | $11.3M | 1.8% | 2,142,348 | Added |
| Balyasny Asset Management L.P. | $10.7M | 1.7% | 2,023,470 | Trimmed |
| Silverarc Capital Management, LLC | $10.3M | 1.6% | 1,946,482 | New |
| Citadel Advisors LLC | $9.3M | 1.5% | 1,762,081 | Trimmed |
| Jones Hill Capital LP | $9.3M | 1.5% | 1,759,492 | New |
| Acadian Asset Management LLC | $8.7M | 1.4% | 1,641,472 | Added |
| Palo Alto Investors LP | $8.5M | 1.3% | 1,613,430 | Unchanged |
| Woodline Partners LP | $8.5M | 1.3% | 1,611,054 | Added |
| Vanguard Portfolio Management LLC | $7.8M | 1.2% | 1,465,735 | Trimmed |
| Panagora Asset Management Inc | $7.2M | 1.1% | 1,356,152 | Added |
| Connor, Clark & Lunn Investment Management Ltd. | $6.4M | 1.0% | 1,209,886 | Trimmed |
| MPM Bioimpact LLC | $5.5M | 0.9% | 1,042,467 | Added |
Share of 13F holdings is each fund's shares as a share of the 121,170,637 ACRS shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- Ra Capital Management, L.p. Added+$31.3M
- BlackRock, Inc. Added+$13.9M
- Silverarc Capital Management, LLC New+$10.3M
- Jones Hill Capital LP New+$9.3M
- State Street Corp Added+$6.6M
- Panagora Asset Management Inc Added+$4.5M
- Geode Capital Management, LLC Added+$4.1M
- MPM Bioimpact LLC Added+$3.4M
- Vanguard Capital Management LLC Added+$3.4M
- Kalehua Capital Management LLC Added+$2.6M
Biggest sellers in Q2 2026
- Morgan Stanley Trimmed-$13.8M
- BML Capital Management, LLC Trimmed-$12.0M
- Balyasny Asset Management L.P. Trimmed-$7.1M
- Marshall Wace, LLP Sold out-$2.7M
- Citadel Advisors LLC Trimmed-$2.6M
- D. E. Shaw & Co., Inc. Trimmed-$2.6M
- Monashee Investment Management LLC Sold out-$1.9M
- Logos Global Management LP Trimmed-$1.6M
- Two Sigma Investments, LP Trimmed-$1.4M
- Bridgeway Capital Management, LLC Trimmed-$1.3M
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $116M and sold $56.5M; 68 added and 31 trimmed.
Schedule 13D and 13G filings on ACRS
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-04-07RA CAPITAL MANAGEMENT, L.P. SCHEDULE 13G filed by Aclaris Therapeutics Inc.Schedule 13G
- 2025-07-29VANGUARD GROUP INC SCHEDULE 13G filed by Aclaris Therapeutics Inc.Schedule 13G
- 2025-07-17BlackRock, Inc. SCHEDULE 13G filed by BlackRock Inc.Schedule 13G
- 2025-05-05MILLENNIUM MANAGEMENT LLC SCHEDULE 13G filed by Aclaris Therapeutics Inc.Schedule 13G
- 2025-02-12Adage Capital Management, L.P. SCHEDULE 13G filed by Aclaris Therapeutics Inc.Schedule 13G
Questions about ACRS ownership
- Who owns ACRS stock?
- 149 institutional investment managers reported ACRS positions in their Form 13F filings for Q2 2026, holding 121,170,637 shares worth $641M in total. Ra Capital Management, L.p. reported the largest position.
- Are funds buying or selling ACRS?
- In Q2 2026, 28 managers opened new ACRS positions, 68 added, 31 trimmed and 14 sold out. Managers that filed in both quarters added a net 10,622,779 shares.
- How current is this ACRS institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to ACRS by CUSIP. Options are left out. ACRS news and filings · ACRS insider trades · Top funds